SI2721009T1 - Derivati pirazola uporabni kot inhibitorji aldosteron sintaze - Google Patents

Derivati pirazola uporabni kot inhibitorji aldosteron sintaze

Info

Publication number
SI2721009T1
SI2721009T1 SI201230283T SI201230283T SI2721009T1 SI 2721009 T1 SI2721009 T1 SI 2721009T1 SI 201230283 T SI201230283 T SI 201230283T SI 201230283 T SI201230283 T SI 201230283T SI 2721009 T1 SI2721009 T1 SI 2721009T1
Authority
SI
Slovenia
Prior art keywords
synthase inhibitors
pyrazole derivatives
derivatives useful
aldosterone synthase
aldosterone
Prior art date
Application number
SI201230283T
Other languages
English (en)
Slovenian (sl)
Inventor
Michael Gregory Bell
Paul J. Hoogestraat
Thomas Edward Mabry
Quanrong Shen
Ana Maria Escribano
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46317515&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2721009(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of SI2721009T1 publication Critical patent/SI2721009T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/4161,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SI201230283T 2011-06-14 2012-06-07 Derivati pirazola uporabni kot inhibitorji aldosteron sintaze SI2721009T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161496657P 2011-06-14 2011-06-14
US201161506349P 2011-07-11 2011-07-11
PCT/US2012/041212 WO2012173849A1 (en) 2011-06-14 2012-06-07 Pyrazole derivatives useful as aldosterone synthase inhibitors
EP12727984.2A EP2721009B1 (en) 2011-06-14 2012-06-07 Pyrazole derivatives useful as aldosterone synthase inhibitors

Publications (1)

Publication Number Publication Date
SI2721009T1 true SI2721009T1 (sl) 2015-10-30

Family

ID=46317515

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201230283T SI2721009T1 (sl) 2011-06-14 2012-06-07 Derivati pirazola uporabni kot inhibitorji aldosteron sintaze

Country Status (33)

Country Link
US (1) US8778984B2 (enExample)
EP (1) EP2721009B1 (enExample)
JP (1) JP5890012B2 (enExample)
KR (1) KR101555119B1 (enExample)
CN (1) CN103596930B (enExample)
AR (1) AR086665A1 (enExample)
AU (1) AU2012271023A1 (enExample)
BR (1) BR112013031873A2 (enExample)
CA (1) CA2836804C (enExample)
CL (1) CL2013003536A1 (enExample)
CO (1) CO6821955A2 (enExample)
CR (1) CR20130601A (enExample)
CY (1) CY1116687T1 (enExample)
DK (1) DK2721009T3 (enExample)
DO (1) DOP2013000284A (enExample)
EA (1) EA201391655A1 (enExample)
EC (1) ECSP13013080A (enExample)
ES (1) ES2548210T3 (enExample)
GT (1) GT201300307A (enExample)
HR (1) HRP20150939T1 (enExample)
HU (1) HUE026461T2 (enExample)
IL (1) IL229485A0 (enExample)
ME (1) ME02223B (enExample)
MX (1) MX336042B (enExample)
PE (1) PE20140606A1 (enExample)
PH (1) PH12013502597A1 (enExample)
PL (1) PL2721009T3 (enExample)
PT (1) PT2721009E (enExample)
RS (1) RS54269B1 (enExample)
SG (1) SG194822A1 (enExample)
SI (1) SI2721009T1 (enExample)
TW (1) TWI518073B (enExample)
WO (1) WO2012173849A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170253577A1 (en) 2014-07-04 2017-09-07 Japan Tobacco Inc. Method for producing indole compound
CN108586221B (zh) * 2018-06-26 2021-03-02 常州制药厂有限公司 用于制备替卡格雷的中间体及其制备方法
CN112409432B (zh) * 2020-11-16 2023-07-07 陕西理工大学 一种依西美坦的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57165369A (en) * 1981-04-06 1982-10-12 Teijin Ltd Pyrazole derivative and its preparation
US4617307A (en) 1984-06-20 1986-10-14 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
US5057521A (en) 1988-10-26 1991-10-15 Ciba-Geigy Corporation Use of bicyclic imidazole compounds for the treatment of hyperaldosteronism
GT200600381A (es) * 2005-08-25 2007-03-28 Compuestos organicos
JPWO2007111175A1 (ja) 2006-03-17 2009-08-13 日本碍子株式会社 目封止ハニカム構造体の製造方法
EP2507234B1 (en) 2009-11-30 2014-03-12 Novartis AG Imidazole derivatives as aldosterone synthase inhibitors
CN102711916B (zh) 2010-01-14 2015-09-02 诺华股份有限公司 肾上腺激素调节剂的用途

Also Published As

Publication number Publication date
CA2836804A1 (en) 2012-12-20
AU2012271023A1 (en) 2013-11-28
ME02223B (me) 2016-02-20
MX2013014790A (es) 2014-01-24
EP2721009A1 (en) 2014-04-23
BR112013031873A2 (pt) 2016-12-13
KR20140009564A (ko) 2014-01-22
CL2013003536A1 (es) 2014-07-11
WO2012173849A1 (en) 2012-12-20
EP2721009B1 (en) 2015-08-12
PL2721009T3 (pl) 2016-01-29
KR101555119B1 (ko) 2015-09-22
CR20130601A (es) 2014-05-02
CN103596930B (zh) 2015-05-13
PH12013502597A1 (en) 2018-04-11
TW201311647A (zh) 2013-03-16
ES2548210T3 (es) 2015-10-14
JP2014517034A (ja) 2014-07-17
PT2721009E (pt) 2015-10-23
HUE026461T2 (en) 2016-05-30
DOP2013000284A (es) 2014-06-30
JP5890012B2 (ja) 2016-03-22
RS54269B1 (sr) 2016-02-29
PE20140606A1 (es) 2014-05-17
DK2721009T3 (en) 2015-10-26
CN103596930A (zh) 2014-02-19
EA201391655A1 (ru) 2014-07-30
CA2836804C (en) 2016-05-24
NZ617642A (en) 2015-11-27
HRP20150939T1 (xx) 2015-10-09
ECSP13013080A (es) 2014-01-31
MX336042B (es) 2016-01-07
TWI518073B (zh) 2016-01-21
SG194822A1 (en) 2013-12-30
CO6821955A2 (es) 2013-12-31
CY1116687T1 (el) 2017-03-15
GT201300307A (es) 2014-11-24
US8778984B2 (en) 2014-07-15
US20120322841A1 (en) 2012-12-20
HK1193103A1 (en) 2014-09-12
IL229485A0 (en) 2014-01-30
AR086665A1 (es) 2014-01-15

Similar Documents

Publication Publication Date Title
IL246515B (en) Imidazole derivatives are designed for use as ido inhibitors
ZA201204959B (en) Pyrazole derivatives as jak inhibitors
ZA201305826B (en) Substituted amminobutyric derivatives as neprilysin inhibitors
ZA201305612B (en) Pyrrolotriazinone derivatives as pi3k inhibitors
EP2552208A4 (en) IMIDAZOLYL-IMIDAZOLES AS KINASE INHIBITORS
IL221823A (en) Pipridine-4-Il-Aztidine Derivatives as Jack 1 Suppressors
SI2746265T1 (sl) Heterociklični derivat kot zaviralec mikrosomske prostaglandin-e sintaze (mpges)
EP2552214A4 (en) PYRAZOLYL-PYRIMIDINES AS KINASE INHIBITORS
IL228103A0 (en) Amino-quinolines as kinase inhibitors
EP2552211A4 (en) INDAZOLYL-PYRIMIDINE AS KINASEHEMMER
IL223300A0 (en) Pyrazole compounds as sigma receptor inhibitors
ZA201308939B (en) Pyrazole derivatives
ZA201303607B (en) Imidazole derivatives as pde 10a enzyme inhibitors
PL2588457T3 (pl) Pochodne pirazolochinolinowe jako inhibitory dna-pk
AP2014008044A0 (en) Pyrazole compounds as SGLT1 inhibitors
EP2744788A4 (en) BENZOPIPERAZINE DERIVATIVES AS CETP INHIBITORS
SI2721009T1 (sl) Derivati pirazola uporabni kot inhibitorji aldosteron sintaze
HK1193103B (en) Pyrazole derivatives useful as aldosterone synthase inhibitors
ZA201103204B (en) Phenylpyrazole derivatives